German coalition: EU medtech system needs attention, not centralised approvals
This article was originally published in Clinica
Executive Summary
And now for the main course. If Q4 2012 was the entrée in terms of initial position-taking in the EU medtech regulatory debate, 2013 will be the plat principal, and, with apologies to the chef, it will certainly be a chewy one.